Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Credit: Artur Plawgo / Science Photo Library via A 21-year-old man has become the first person in New York—and ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

This month, 21-year-old Sebastien Beauzile became the first man in New York history to be cured of sickle cell anemia, a genetic blood disorder, thanks to a new form of gene therapy. “ ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the introduction of CASGEVY, the first CRISPR/Cas9 gene-editing therapy in the UAE.